# Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors

> **NCT00061893** · PHASE2 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 38 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** celecoxib
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate
- **PROCEDURE:** conventional surgery
- **RADIATION:** radiation therapy
- **DRUG:** MESNA
- **DRUG:** Filgrastim

## Key facts

- **NCT ID:** NCT00061893
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** 2008-04
- **Final completion:** 2013-12
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00061893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00061893, "Vinblastine, Celecoxib, and Combination Chemotherapy in Treating Patients With Newly-Diagnosed Metastatic Ewing's Sarcoma Family of Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00061893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*